Patents Assigned to TICURE LTD.
  • FABP4 as a therapeutic target in skin diseases
    Patent number: 11229624
    Abstract: Provided are methods of regulating proliferation and/or differentiation of keratinocytes and immune cells, more specifically to methods of treating pathologies characterized by hyperproliferative keratinocytes or inflammatory skin diseases by administration of FABP4-inhibitor.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: January 25, 2022
    Assignee: TICURE LTD.
    Inventor: Tali Garin-Shkolnik
  • FABP4 AS A THERAPEUTIC TARGET IN SKIN DISEASES
    Publication number: 20200138779
    Abstract: Provided are methods of regulating proliferation and/or differentiation of keratinocytes and immune cells, more specifically to methods of treating pathologies characterized by hyperproliferative keratinocytes or inflammatory skin diseases by administration of FABP4-inhibitor.
    Type: Application
    Filed: October 25, 2017
    Publication date: May 7, 2020
    Applicant: TICURE LTD.
    Inventor: Tali GARIN-SHKOLNIK